The Development and Impact of Hemostatic Stewardship Programs

Kathryn E. Dane, Michael B. Streiff, John Lindsley, Manuela Plazas Montana, Satish Shanbhag

Research output: Contribution to journalReview article

Abstract

The approval of several new clotting factor concentrates and anticoagulation antidotes has resulted in increased complexity and cost of care. A multidisciplinary hemostatic stewardship program is essential to optimize utilization of these resources. This article summarizes the authors’ approach to the stewardship of clotting factor concentrates and anticoagulation antidotes.

Original languageEnglish (US)
Pages (from-to)887-901
Number of pages15
JournalHematology/Oncology Clinics of North America
Volume33
Issue number5
DOIs
StatePublished - Oct 2019

Keywords

  • Anticoagulation reversal
  • Hemophilia
  • Stewardship
  • Von Willebrand's disease
  • clotting factor concentrates

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'The Development and Impact of Hemostatic Stewardship Programs'. Together they form a unique fingerprint.

  • Cite this